雷米芬坦尼尔减轻刺激诱导的口腔组织 血流变化
Anesthesia progress
|March 6, 2026
概括
在吸入麻醉期间输注雷米芬坦尼尔缓解了有害口腔刺激引起的血液动力学和口腔组织血流变化. 这种干预有助于维持子的口腔组织氧气张力.
科学领域:
- 麻醉学 麻醉学
- 在口腔外科手术.
- 生理学 生理学 生理学
背景情况:
- 有害的口腔刺激可以诱导显著的血液动力学和局部组织 perfusion 变化.
- 了解麻醉剂对这些反应的影响对于患者安全至关重要.
- 吸入麻醉剂,如sevoflurane和desflurane是常用的,但它们与Remifentanil等辅助剂的相互作用需要进一步研究.
研究的目的:
- 为了研究在吸入麻醉期间注射雷米芬坦尼尔对口腔组织血流和氧气张力的影响.
- 评估雷米芬坦尼尔对有害口腔刺激的血液动力学反应的影响.
- 评估雷米芬坦尼尔在维持口腔区域组织氧化的作用.
主要方法:
- 十六只日本白的雄性被麻醉了sevoflurane或desflurane.
- 血液动力学参数 (SBP,DBP,MAP,HR) 和口腔组织血流 (BBF,MBF) 和氧气张力 (PbO2,PmO2) 被测量.
- 在电刺激之前和之后进行测量,有和没有注入雷米芬坦尼尔.
主要成果:
- 雷米芬坦尼尔显著降低了静缩血压,静缩血压,平均血压,下骨髓血流和按摩肌肉血流的变化速度.
- 口腔组织氧气张力 (PbO2和PmO2) 保持不变,尽管有毒刺激当Remifentanil被管理.
- 雷米芬坦尼尔减轻了由电刺激引起的血液动力学和血液流动波动.
结论:
- 雷米芬坦尼尔输液有效地抑制了由有害的口腔刺激引起的血动力学和口腔组织血流变化.
- 在吸入麻醉下使用雷米芬坦尼尔有助于保持稳定的口腔组织氧气张力.
- 雷米芬坦尼尔似乎是一个有价值的辅助,用于在麻醉期间管理对口腔区域有害刺激的反应.
更多相关视频
08:49Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
Published on: October 16, 2013
14.6K
06:40Combined Infusion and Stimulation with Fast-Scan Cyclic Voltammetry CIS-FSCV to Assess Ventral Tegmental Area Receptor Regulation of Phasic Dopamine
Published on: April 23, 2020
3.8K
相关概念视频
Parenteral Anesthetics: Overview
844
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
844
Local Anesthetics: Pharmacokinetics
1.4K
The potency and duration of action of local anesthetics (LAs) are determined by their pharmacokinetics. Pharmacokinetics describes how LAs are absorbed, distributed, metabolized, and eliminated from the body. When administered to the vascular tissues, LAs are quickly absorbed and enter the systemic circulation, reducing their localized effects. Adding vasoconstrictors such as epinephrine to LAs reduces their absorption into the systemic circulation, making them clinically effective. The...
1.4K
